Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant

Autologous stem cell transplant (ASCT) is still considered an effective option for first-line treatment in transplant eligible young patients with multiple myeloma (MM), even in the era of novel ag...